Polymer stabilized cholesteric liquid crystals (PSCLCs) provide many advantages over other electro-optical materials. The unique helical structure of the cholesteric liquid crystal (CLC) creates a natural gradient for light interacting across each CLC domain layer. Not only does the CLC helical structure greatly increase the bandwidth tuning and broadening range, it also allows CLCs to act as a polarizer, notch filter, reflector, and optical rotator all in one material. However, while many novel PSCLC materials have been created, little is understood about how complex initial system interactions affect final electro-optical (e-o) properties.1,2 In this work, the principal variables affecting PSCLC blue shift electro-optical behavior have been determined through structural analysis and measurement of electro-optical properties. Typical PSCLC materials must meet both formulation and photopolymerization processing requirements to display blue shift e-o properties. Threshold photoinitiator concentrations (0.5-1.5 wt%) and morpholine containing group concentrations (0.25-1.0 wt%) were both shown to be primary factors, along with sufficient UV exposure time (10-30 min) and light intensity (500 mW/cm2, 365 nm), for PSCLC blue shift bandwidth tuning/broadening to occur. Morpholine was initially identified as a component of photoinitators Irgacure 369 and 907 and was proven to increase PSCLC ion density altering LC-polymer network interactions with several proposed theories included later in this work. The use of an appropriate morpholine containing LC monomer to directly incorporate morpholine into the LC-polymer network was shown to greatly improve PSCLC sample stability. Through the results of this research we successfully induced blue shift e-o behavior in a previous red shift only PSCLC using only 30% of the UV exposure that a model PSCLC blue shift sample required while extending the blue shift broadening range over threefold (from 75 nm to 250 nm). The fundamental understanding and design of PSCLC systems described herein serves as a starting point for engineering PSCLC materials with specific and desirable electro-optical properties.

No description available.

Polyethylene glycol-stabilized lipodisks have emerged as a novel type of lipid-based nanoparticles with high potential as both drug carriers and biomimetic membranes. In this thesis we assess both of these applications, and show how the properties of the lipodisks can be further developed and optimized. Initially, we show that the antimicrobial peptides melittin, alamethicin and magainin 2, in spite of their very different physico-chemical properties and suggested modes of action on membranes, all have high affinity to lipodisks. Using melittin as a model peptide, we confirm a maintained antimicrobial effect of disk-formulated peptides. We also show that melittin dissociates slowly from the disks, resulting in extended drug release and prolonged antibacterial effect. Additionally, we present evidence that the peptide is protected against enzymatic degradation when formulated in the disks. Further, we develop a stable HPLC-MS system with immobilized lipodisks as model membranes. The stability of the system is confirmed by drug partitioning analysis using 15 different drug compounds. We also show how the lipodisk column can be supplemented with cyclooxygenase by in situ incorporation of the protein in the lipodisks. The specific binding of the protein to the disks is confirmed using QCM-D. Finally, by changing the polymer length and applying a new preparation protocol, we have optimized the lipodisks for use as drug carriers and biomimetic membranes. Previous lipodisk studies have been conducted on systems containing PEG-lipids with polymer molecular weights of 2000 or 5000 Da. Also, conventional protocols for the preparation of lipodisks typically require a PEG-lipid concentration of 15 mol% or more. Here we show that stable lipodisks can also be produced using PEG-lipids with a 1000 Da molecular weight polymer and that the use of shorter PEG-lipids dramatically improve the amount of lipodisks that can be immobilized on silica surfaces. Moreover, through the development of a method in which lipid mixtures are sonicated at low temperatures, we produce lipodisks containing as little as 2 mol% PEG-lipid. We present data verifying that these disks are superior to disks with higher PEG-lipid content in terms of their ability to incorporate externally added PEG-lipids functionalized with targeting agents.

No description available.

No description available.

No description available.

No description available.